Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

US Patent 7829086 · Granted Nov 9, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

D-domain containing polypeptides and uses thereof2025
De novo binding domain containing polypeptides and uses thereof2025
System for simulating and creating smart purchase agreements from master service2023
Multifunctional immune cell therapies2023
Chimeric antibodies for treatment of amyloid deposition diseases2022
D-domain containing polypeptides and uses thereof2022
D-domain containing polypeptides and uses thereof2022
D-domain containing polypeptides and uses thereof2022
Humanized anti-AXL antibodies2021
De novo binding domain containing polypeptides and uses thereof2021
System and method for creating and operating low-power wide area network for int2020
De novo binding domain containing polypeptides and uses thereof2020